Morse Asset Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-13,040
| Closed | -$1.02M | – | 141 |
|
|
2019
Q1 | $1.02M | Sell |
13,040
-1,788
| -12% | -$140K | 0.31% | 71 |
|
|
2018
Q4 | $1.26M | Sell |
14,828
-1,170
| -7% | -$99K | 0.45% | 56 |
|
|
2018
Q3 | $2.74M | Buy |
15,998
+160
| +1% | +$27.4K | 0.72% | 44 |
|
|
2018
Q2 | $2.05M | Buy |
15,838
+5,643
| +55% | +$729K | 0.56% | 52 |
|
|
2018
Q1 | $1.05M | Buy |
10,195
+4,576
| +81% | +$471K | 0.29% | 81 |
|
|
2017
Q4 | $480K | Sell |
5,619
-22,361
| -80% | -$1.91M | 0.13% | 100 |
|
|
2017
Q3 | $2.38M | Buy |
27,980
+13,745
| +97% | +$1.17M | 0.71% | 50 |
|
|
2017
Q2 | $1.08M | Buy |
+14,235
| New | +$1.08M | 0.35% | 73 |
|